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Abstract 
The adoption of neurotransmitter phenotype is a crucial step in the development 
of the nervous system.  Ca2+ transients have been shown to play a critical role by 
modulating neurotransmitter phenotype specification during differentiation.  The 
mechanisms by which this occurs remain unclear, but given that Ca2+ affects terminal 
differentiation gene expression, transcription factors may be regulated by the Ca2+ 
transients.  As a first necessary step in elucidating the effects of Ca2+ on transcription 
factors in neuronal development, we have characterized the coexpression patterns of 
transcription factors with terminal differentiation genes to provide a baseline for future 
studies.  We have found that the transcription factors xDlx2 and xDlx5 colocalize 
extensively with both xGAD67 and xVIAAT in the telencephalon and diencephalon in 
very similar patterns.  xPitx2 is coexpressed moderately with both xGAD67 and xGAT1 in 
the midbrain, and xPtf1a colocalizes moderately with xGAD67 in the retina.  Xbh1 
colocalizes extensively with xGlyT1 in the retina.  Interestingly, xPitx2 is expressed 
mutually exclusive to xGAD67 and xGAT1 in the diencephalon with virtually no 
colocalization.  Similarly, Xbh1 is expressed in a mutually exclusive pattern to xGAD67 
and xVIAAT in the midbrain.  All of these observations lead to several conclusions, 
among them that the similar coexpression patterns observed for xGAD67, xGAT1, and 
xVIAAT with several transcription factors suggest that the GABAergic terminal 
differentiation genes are all subject to similar transcriptional regulatory mechanisms.  
Furthermore, the mutually exclusive expression patterns observed suggest that either 
negative regulatory mechanisms or signaling mechanisms play a role in the specification 
of GABAergic terminal differentiation genes in certain regions of the central nervous 
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system.  Finally, overlap observed in transcription factor expression patterns, a 
transcription factor binding site analysis, and the variability of transcription factor 
expression along the anterior-posterior axis suggest that inhibitory neurotransmitter 
phenotype specification is controlled by multiple transcription factors in a combinatorial 
fashion. 
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1. Introduction 
The adult central nervous system is composed of neurons with hundreds of 
distinct types (Masland, 2004).  Understanding how these neuronal fates are specified 
during development is a major question in neurobiology that has yet to be answered.  
Among the important aspects of a mature neuron’s phenotype is the neurotransmitter (or 
neurotransmitters) that it releases.  The adoption of neurotransmitter phenotype is a 
critical step in the proper development of the nervous system and requires extensive 
coordination of gene expression to ensure that the appropriate terminal differentiation 
genes involved in neurotransmission are activated.   
Several distinct but interacting mechanisms may play a role in the specification of 
neurotransmitter phenotype.  Cell-cell interactions mediated by juxtacrine signaling 
mechanisms have been shown to play a role in cell type specification in neural 
development (Perron and Harris, 2000).  The time of exit from the cell cycle may also 
control neurotransmitter phenotype specification (Ma, 2006).  Perhaps the most pervasive 
effectors of neuronal development are transcription factors, which often act in cascades 
or combination to specify neuronal fate at the level of the individual neuron (Goridis and 
Brunet, 1999; Ma, 2006).  While a number of transcription factors necessary for 
neurotransmitter phenotype specification have been identified, how these factors 
coordinate temporally and spatially in order to produce specific phenotypes is not well 
understood. 
However, these “hard-wired”, genetically based mechanisms are not the only key 
regulators of neural identity—recent work has revealed that specific patterns of calcium 
ion (Ca2+) activity in the developing nervous system may play a critical role in 
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development.  Ca2+ signaling has been implicated in a broad range of processes from 
neural induction to neuronal specification and differentiation in multiple model 
organisms (Leclerc et al., 2000; Webb and Miller, 2006).   More specifically, Ca2+ 
transients modulate the specification of neurotransmitter phenotypes in differentiating 
neurons, particularly the GABAergic and glutamatergic phenotypes (Spitzer et al., 2000; 
Watt et al., 2000; Borodinsky et al., 2004). 
The mechanisms by which Ca2+ regulates neuronal specification remain unclear, 
although Ca2+ does appear to alter terminal differentiation gene expression (Watt et al., 
2000).  As such, the transcription factors that control the terminal differentiation genes 
could mediate the effects of Ca2+ on neuronal identity.  This thesis addressed the first 
necessary step in determining if Ca2+ transients might be affecting the transcription 
factors regulating neurotransmitter phenotype differentiation genes.  The major question 
it focused on was determining what the baseline, endogenous expression patterns of 
transcription factors involved in neurotransmitter phenotype specification are, as well as 
the colocalization patterns of these transcription factors with terminal differentiation 
genes.  This will allow future work where Ca2+ concentrations are manipulated in the 
developing embryo followed by an analysis of transcription factor colocalization with 
terminal differentiation genes, to demonstrate if Ca2+ activity-dependent effects on 
neurotransmitter phenotype identity are mediated by Ca2+ regulation of transcription 
factor expression. 
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2. Background 
2.1. Inhibitory neurotransmitter phenotypes 
The most prevalent inhibitory neurotransmitter in the vertebrate nervous system is 
γ-aminobutyric acid (GABA) (Makinae et al., 2000).  In addition to its long-established 
and broad role as an inhibitory neurotransmitter at the synapse in organisms as 
evolutionarily diverse as Caenorhabditis elegans and humans, GABA has been 
implicated in several developmental signaling roles prior to synapse formation in 
vertebrates: it appears to modulate DNA synthesis, neuronal migration, and neuronal 
growth and morphology in various neuronal precursors (reviewed in Ben-Ari et al., 
2007).  GABA also acts as the de facto excitatory neurotransmitter in early development, 
before glutamatergic neurotransmission is established (reviewed in Ben-Ari et al., 2007). 
GABAergic neurons are characterized by a suite of terminal differentiation genes 
required for the synthesis, release, and reuptake of GABA.  GABA is synthesized from 
glutamate by the enzyme glutamic acid decarboxylase (GAD), which exists as two 
distinct isoforms encoded by two different genes (Chattopadhyaya et al., 2007).  GABA 
is then sequestered into vesicles that release it into the synaptic cleft by the vesicular 
inhibitory amino acid transporter (VIAAT) (McIntire et al., 1997).  Sodium-coupled 
transport systems encoded by multiple GABA transporter genes (GATs) remove GABA 
from the synaptic cleft after synaptic transmission via uptake into the presynaptic space 
(Nelson et al., 1990).   
Another important and prevalent inhibitory neurotransmitter in the vertebrate 
nervous system, particularly in the spinal cord, is the amino acid glycine.  Like GABA, 
glycine has been implicated in a wide variety of developmental functions in addition to 
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its inhibitory synaptic role: it promotes interneuron differentiation (McDearmid et al., 
2006), modulates glutamatergic neurotransmission by binding to N-methyl-D-aspartic 
acid (NMDA) receptors (reviewed in Betz et al., 2006), elevates intracellular calcium 
levels, and regulates synaptic remodeling of some inhibitory pathways (Kandler and 
Friauf, 1995).  Glycine signaling also plays a major role in some motor functions, as it 
produces rhythmic swimming movements in lower vertebrates (Soffe et al., 2001). 
Like GABAergic neurons, functional glycinergic neurons must express a set of 
terminal differentiation genes in order to release and reuptake glycine, though no unique 
synthetic enzyme is required to produce it, since uptake of extracellular glycine is 
sufficient for neurotransmission.  Glycine is packaged into synaptic vesicles by the same 
protein required for packaging GABA, VIAAT (Wojcik et al., 2006).  In addition, two 
differentially expressed glycine transporter proteins (GlyT1 and GlyT2) are responsible 
for the reuptake of glycine into the presynaptic neuron following neurotransmission (Betz 
et al, 2006). 
 
2.2. Ca2+ in neuronal specification 
Many studies have illustrated the relationship between Ca2+ activity and neural 
development, particularly relevant to GABAergic phenotypes.  Ca2+ activity in 
developing Xenopus laevis spinal neurons has been characterized by Gu et al. (1994) by 
imaging a fluorescent Ca2+ indicator dye.  These results show two kinetically distinct 
spontaneous fluctuations, or transients, in intracellular Ca2+ during developmental 
stages—spikes and waves.  Ca2+ spikes involve calcium-dependent action potentials and 
can thus be propagated throughout a neuron, lasting ten seconds on average and occurring 
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at a frequency of one to ten times per hour.  Pharmacological manipulations show that 
Ca2+ spikes depend on both influx of extracellular Ca2+ via voltage-gated channels and 
release of intracellular Ca2+ stores via ryanodine receptors (Spitzer et al., 2000).  In 
contrast, Ca2+ waves do not involve action potentials, and thus occur locally with a 
distance-dependent decay in effect.  They have a mean duration of 30 seconds and occur 
at a frequency of eight to nine times per hour with less amplitude than spikes.  Like 
spikes, waves appear to depend upon both Ca2+ influx and release from intracellular 
stores (Spitzer et al., 2000). 
Ca2+ waves and spikes appear to regulate different processes in the developing 
nervous system.  Gu et al. (1994) observed that both removal of extracellular Ca2+ and 
reduction in intracellular Ca2+ promote neurite outgrowth, consistent with previous 
reports.  This suggests that in the growth cone, waves regulate neurite extension.  Spikes, 
unlike waves, significantly alter Ca2+ concentrations in the nuclear region and soma in 
general, leading Gu et al. (1994) to suggest that Ca2+ spikes could play a role in terminal 
differentiation by regulating calcium-dependent gene expression. 
Studies of the relationship between Ca2+ transients and specific neurotransmitter 
phenotypes have focused on the effects of Ca2+ spike frequency on GABAergic 
specification.  Gu and Spitzer (1995) imposed artificial patterns of Ca2+ transient activity 
on cultured X. laevis spinal neurons, observing that only patterns mimicking the 
endogenous frequencies of spikes resulted in normal neurotransmitter phenotype 
differentiation as measured by GABA immunoreactivity.  More recent work shows that 
cultured neurons in the presence of extracellular Ca2+, which allows for spontaneous Ca2+ 
transients, express xGAD67 transcripts at a threefold greater level than in cultured 
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neurons in the absence of extracellular Ca2+.  Additionally, stimulation of Ca2+ spikes at 
frequencies similar to endogenous activity in cultured neurons causes an upregulation of 
xGAD67 transcripts (Watt et al., 2000).  Borodinsky et al. (2004) observed that 
suppression of Ca2+ spike activity results in an increase in neurons expressing excitatory 
markers and a decrease in neurons expressing inhibitory markers, while enhancement of 
Ca2+ spike activity results in an increase in neurons expressing inhibitory markers and a 
decrease in neurons expressing excitatory markers.  These results suggest a homeostatic 
mechanism of neurotransmitter phenotype regulation, where increased Ca2+ activity 
triggers increased inhibitory fate, and vice versa.  Borodinsky et al. (2004) propose that 
activity and gene expression influence one another as the nervous system develops in a 
mechanism that stabilizes fluctuating neuronal identities as maturation occurs. 
Despite the body of work connecting Ca2+ activity and neurotransmitter 
phenotype identity, the mechanism by which Ca2+ regulates this specification remains 
unclear.  However, given that Ca2+ spikes can alter the expression of terminal 
differentiation genes such as GAD, one possible mechanism is that Ca2+ spike activity 
directly or indirectly affects the transcription factors controlling terminal differentiation 
gene expression. 
 
2.3. Mechanisms of Ca2+ regulation of gene expression 
  As a result of the broad roles for Ca2+ signaling in cellular function, the 
mechanisms by which Ca2+ alters gene expression have been explored in several studies.  
Dolmetsch et al. (1998) used a Ca2+ clamp technique to examine the response of the pro-
inflammatory transcription factors NF-AT, Oct/OAP, and NF-κB in T lymphocytes to 
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varying Ca2+ transient frequencies.  For all three transcription factors, Ca2+ oscillations 
decreased the activation threshold, but even more interestingly, an oscillation frequency-
dependent response emerged—rapid Ca2+ oscillations stimulated NF-AT, Oct/OAP, and 
NF-κB, but infrequent Ca2+ oscillations activated only NF-κB.  These results indicate that 
different transcription factors have varying Ca2+ sensitivities and kinetics in response to 
changes in intracellular Ca2+, providing a mechanism by which cells can respond to 
differing Ca2+ conditions.  Remarkably, the observations of transcription factor Ca2+ 
dependence are consistent with the observed Ca2+ dependence of interleukin (IL)-2 and 
IL-8 expression.  IL-2, which depends upon NF-AT and Oct/OAP, is activated by rapid 
Ca2+ transients, while IL-8, which depends on NF-κB, is activated by infrequent Ca2+ 
transients (Dolmetsch et al., 1998).  These results suggest that the Ca2+ sensitivity of IL-2 
and IL-8 are a consequence of the Ca2+ sensitivity of the transcription factors which 
activate the interleukins.  The current model suggested by Fisher et al. (2006) predicts 
that NF-AT activation only by high Ca2+ oscillation frequencies depends on calcineurin.  
High frequency Ca2+ activity activation of calcineurin maintains dephosphorylation of 
NF-AT, allowing it to remain in the nucleus.  Conversely, NFκB can be activated by low 
frequency oscillations because the degradation of IκB, which allows translocation of 
NFκB into the nucleus, is dependent only on the presence of Ca2+, not the frequency of 
oscillations (Fisher et al., 2006). 
Another well-studied Ca2+-dependent gene is brain-derived neurotrophic factor 
(BDNF), a small secreted protein critical to neuronal survival in the central nervous 
system (West et al., 2001).  Recent work has identified some of the molecular 
mechanisms responsible for BDNF sensitivity to Ca2+ and suggests more general 
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mechanisms of Ca2+-mediated changes in gene expression.  West et al. (2001) reviewed 
three major components responsible for the Ca2+ dependence of BDNF: the route of Ca2+ 
influx, the phosphorylation pattern induced on the cAMP-response element (CRE), and 
the complement of transcription factors recruited to the BDNF promoter.  Ca2+ influx 
through Ca2+ channels triggers a number of signaling molecules, including calcium-
sensitive adenylate cyclase, calcium/calmodulin-activated kinases, and Ras, each of 
which initiates independent signaling cascades that ultimately affect CRE binding protein 
(CREB).  It is the Ca2+-sensitive modulation of CREB that directly affects BDNF 
transcription (West et al., 2001).  This study provides a large framework of possible 
mechanistic components of Ca2+ dependence of transcription factor expression, some of 
which may be relevant to Ca2+-sensitive neurotransmitter phenotype specification. 
 
2.4. Transcription factors in inhibitory specification 
In vivo and in vitro studies of GABAergic and glycinergic specification indicate 
that many possible transcription factors specify inhibitory phenotypes and could act as 
intermediates in the Ca2+-mediated specification of neurotransmitter phenotype identity.  
Experimental evidence suggests involvement of the distal-less homeobox (Dlx) 
transcription factor family in specifying a GABAergic fate.  Ectopic expression of Dlx2 
and Dlx5 in mouse telencephalon slices has been shown to induce increased expression of 
both isoforms of GAD.  In addition, Dlx family members may cross regulate themselves, 
as Dlx5 expression can be induced in slice cultures by ectopic expression of Dlx2 
(Stühmer et al., 2002).  A subsequent study established that Dlx5–/– mice experience a 
prominent decrease in GAD67 expression in the olfactory bulb (Long et al., 2003).  
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Kuwajima et al. (2006) found that necdin, a paternally-expressed MAGE (melanoma 
antigen) protein family member, binds to a homologous MAGE protein MAGE-D1; the 
necdin-MAGE-D1 complex then associates with Dlx family transcription factors to form 
a ternary complex.  When overexpressed in mouse forebrain slices, necdin significantly 
increased the population of cells expressing GABAergic markers GAD and calbindin D-
28k, and enhanced the expression levels of these markers within cells.  Further 
investigation revealed that in mutant mice lacking a paternal necdin allele, forebrain 
expression of calbindin D-28k, GAD, and Dlx5 were significantly reduced, while Dlx2 
expression was unchanged; conversely, expression in the dorsal telencephalon was 
unchanged (Kuwajima et al., 2006).  This suggests Dlx2 acts to induce GABAergic 
terminal differentiation genes and Dlx5, and is enhanced by necdin in a region-specific 
pattern. 
In addition to the distal-less family, the paired-like homeodomain transcription 
factor 2 (Pitx2) appears to play a role in GABAergic specification.  Eastman et al. (1999) 
have demonstrated that the UNC-30 homeodomain protein directly activates the 
expression of both unc-25 (glutamic acid decarboxylase) and unc-47 (GABA transporter) 
in type D motor neurons in C. elegans.  Westmoreland et al. (2001) observed 
homeodomain similarity between C. elegans UNC-30 and mammalian Pitx2, a 
transcription factor associated with GABAergic neurogenesis in the mesencephalon and 
diencephalon.  Subsequent experimentation established functional conservation between 
the UNC-30 and Pitx2 proteins, wherein Pitx2 rescued GABAergic differentiation defects 
in unc-30 mutants and both Pitx2 and UNC-30 activated the mouse Gad1 promoter.  
Martin et al. (2002) report that PITX2 colocalizes with GABA immunoreactivity in the 
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zona incerta of the diencephalon and specific neuroepithelial domains in the 
mesencephalon.  This evidence suggests that in some neurons, GABAergic differentiation 
may be controlled by a strongly conserved developmental pathway characterized in 
vertebrates by the transcription factor Pitx2. 
Another transcription factor recently implicated in GABAergic and glycinergic 
specification is Ptf1a, a member of the basic helix-loop-helix (bHLH) class of 
transcription factors.  Hoshino et al. (2005) showed that Ptf1a is expressed endogenously 
in GABAergic (but not glutamatergic) precursors, and that introduction of Ptf1a to 
glutamatergic precursors causes a GABAergic morphological and migratory fate.  
Additionally, Glasgow et al. (2005) reported that Ptf1a is necessary for the generation of 
a variety of GABAergic dorsal interneuron populations in the spinal cord dorsal horn.  In 
the absence of Ptf1a, not only is a complete loss of GABAergic interneurons observed, 
but also an increase in glutamatergic neurons.  Therefore, Ptf1a appears to be essential 
for the specification of GABAergic over glutamatergic phenotypes in the spinal cord 
(Glasgow et al, 2005). Additionally, Nakhai et al. (2007) showed that Ptf1a contributes to 
the differentiation of both GABAergic and glycinergic amacrine cells in the mouse retina. 
Finally, recent research suggests that the Bar homeobox family of transcription 
factors play a role in glycinergic, but not GABAergic, terminal differentiation.  Mo et al. 
(2004) recently demonstrated that the mouse BarH-like 2 gene (Barhl2) is expressed in 
postmitotic amacrine cells of the developing retina, and misexpression of Barhl2 directs 
retinal progenitor cells to differentiate into glycinergic amacrine cells.  Patterson et al. 
(1999) have identified two distinct Bar homeobox genes, named Xbh1 and Xbh2, which 
appear to be expressed in distinct regions of the developing central nervous system.  
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Furthermore, Poggi et al. (2004) demonstrated that Xbh1 acts as a transcriptional 
repressor downstream of the atonal genes Xath3 and Xath5, driving ganglion cell fate in 
the developing retina.  The wide body of work on transcriptional regulation of inhibitory 
phenotypes provides an excellent framework of transcription factors to investigate in 
Ca2+ activity-dependent specification. 
 
2.5. Colocalization as an indicator of transcription factor function 
To accurately assess the possible role of transcription factors in mediating Ca2+-
dependent specification, a detailed baseline of transcription factor expression is needed 
for comparison with embryos cultured in differing Ca2+-containing environments.  A 
useful method of observing changes in transcription factor expression is analyzing 
transcription factor coexpression with terminal differentiation genes.  Redestig et al. 
(2007) report that while transcription factor colocalization with a target gene cannot alone 
serve as an absolute indicator of a regulatory relationship, transcription factors do tend to 
coexpress with their target genes.  So long as possible time shifts between a transcription 
factor and its target gene are accounted for, gene expression data can serve as a rough 
proxy for transcription factor activity (Redestig et al., 2007).  Yu et al. (2003) caution 
that the expression relationships between transcription factors and their target genes are 
sometimes more complex than simple correlations, but in agreement with Redestig et al., 
acknowledge that a lack of colocalization is often only due to a time delay.  
Colocalization analyses should allow a correlational, if not functional, connection 
between manipulations in Ca2+ levels, changes in transcription factor gene expression, 
and changes in terminal differentiation gene expression. 
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Because the use of multiplex fluorescent in situ hybridization allows several 
transcripts to be detected simultaneously without interference, it is an ideal technique for 
performing a colocalization analysis between transcription factors and their terminal 
differentiation gene targets.  Fluorescent signal is developed for each probe 
independently using tyramide signal amplification, allowing for dramatic amplification of 
signal intensity and preventing cross-deposition of fluorophores to multiple probes.  
Additionally, the fluorescent signal is detectable by confocal microscopy, allowing for 
single-cell signal resolution and true colocalization analysis (Denkers et al., 2004).  Even 
if a correlation in the change of both a transcription factor and terminal differentiation 
gene target is not observed, the high resolution of the confocal microscopy provides an 
ideal platform to observe any changes in transcription factor expression, even minute, 
induced by manipulations in Ca2+ levels. 
 
2.6. Xenopus laevis as a model system 
Xenopus laevis, the African clawed frog, has been used for investigating 
numerous aspects of early neural development.  The embryos produced by X. laevis are 
easily obtained with the use of artificially-induced matings and develop externally in 
simple salt solutions.  This allows observation of early embryonic stages inaccessible in 
other organisms which develop internally.  Additionally, due to the simple culture 
requirements and manipulability of the embryos, many of the studies on developmental 
roles of Ca2+ transients have been performed in X. laevis (Borodinsky and Spitzer, 2006).  
X. laevis has also been utilized extensively in research of the molecular and genetic 
aspects of early neural development, again due to the accessibility to early stages, 
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including neural induction and subsequent patterning (reviewed in De Robertis, 2006) 
and neurotransmitter phenotype determination and differentiation (Gamse and Sive, 
2000).  Given these advantages, X. laevis is an ideal organism in which to study 
transcription factor colocalization with multiple terminal differentiation genes, and will 
serve as an excellent model in future studies for examining the effects of Ca2+ on the 
expression of transcription factors controlling neuronal specification. 
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3. Hypothesis and predictions 
Given the question of where transcription factors involved in GABAergic and 
glycinergic neurotransmitter phenotype specification are expressed, the existing research 
suggests that transcription factors responsible for driving GABAergic and glycinergic 
terminal differentiation will likely be coexpressed with the terminal differentiation genes 
they control.  This predicts that since the Dlx2, Dlx5, Pitx2, Ptf1a, Xbh1, or Xbh2 
transcription factors are responsible for driving GABAergic or glycinergic differentiation, 
these transcription factors will be coexpressed with the terminal differentiation genes 
(xGAD67, xGlyT1, xGlyT2, or xVIAAT) in a given tissue of the central nervous system.  
Given the variable nature of the transcription factor sets required for expression of the 
same phenotype in different areas along the anterior-posterior axis, it is likely that the set 
of transcription factors that overlap the spatial expression and precede or overlap the 
temporal expression of a given terminal differentiation gene will vary significantly along 
the anterior-posterior axis of X. laevis embryos.  These data provide a strong foundation 
on which to begin a comparative study where Ca2+ levels are manipulated and changes in 
transcription factor expression and coexpression are observed. 
15 
 
 
 
4. Materials and methods 
4.1. Animal use 
Embryos for experimentation were obtained using human chorionic gonadotropin 
(hCG)-induced natural matings of albino X. laevis frogs as described in Sive et al. (2000).  
Animal care and use were performed in adherence to the regulations established by the 
Institutional Animal Care and Use Committee at the College of William and Mary. 
 
4.2. Cloning and sequence analysis 
Total RNA was extracted from X. laevis embryos using the RNeasy Maxi kit 
(Qiagen) according to the manufacturer’s protocol with one exception.  Rather than 
disrupting the tissue samples with a mortar and pestle in liquid nitrogen, tissue samples 
were disrupted with a mortar and pestle quickly at room temperature.  Swimming tadpole 
stage embryos were used for all extractions due to reports that xPtf1a, Xbh1, and Xbh2 
were expressed at high levels at these stages (Afelik et al., 2006; Patterson et al., 2000).  
cDNA was synthesized using the iScript cDNA Synthesis kit (BioRad) according to 
manufacturer’s protocol with one exception.  Instead of a 30 minute 42°C reverse 
transcription step, the time for this step was extended to 60 minutes to improve yield at 
the suggestion of a different manufacturer’s kit.  cDNA was purified with the QIAquick 
PCR Purification kit (Qiagen) according to the manufacturer’s protocols.  Polymerase 
chain reaction (PCR) was performed using Taq DNA polymerase (New England 
Biolabs). 
For xPitx2, xPtf1a, Xbh1, and Xbh2, published X. laevis mRNA sequences in 
GenBank (accession numbers AF077767, DQ007931, NM_001088552, and AF283692, 
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respectively) were used for primer design.  Full mRNA sequences were processed by 
Primer3 primer design software (http://frodo.wi.mit.edu; Rozen and Skaletsky, 2000) 
with selection criteria for product lengths greater than 600 base pairs and less than 1300 
base pairs, primer lengths of 20 base pairs, and primer melting temperatures between 
54.0°C and 60.0°C.  For each transcript, the two distinct primer pairs producing the 
longest products encompassing the full coding sequences and including portions of the 
untranslated region were selected for use.  Primers were used for PCR amplification 
using X. laevis cDNA, with conditions as shown in Table 1. 
PCR products were initially analyzed with agarose gel electrophoresis to confirm 
appropriate sizes, cloned into pCRII-TOPO (Invitrogen), and transformed into One Shot 
TOP10 chemically competent E. coli or One Shot MAX Efficiency DH5α-T1R E. coli 
(Invitrogen) according to the manufacturer’s protocols.  Transformed colonies were 
grown on LB-agar media at 37°C and selected for by addition of ampicillin to the plate.  
Selection for recombinant plasmids was carried out by addition of X-Gal to the plates 
according to standard methods (Sambrook and Russell, 2001).  Individual colonies were 
picked from plates and cultured overnight in LB liquid media, and plasmids were isolated 
from the cultures using the Wizard Plus SV Miniprep kit (Promega).  Purified plasmid 
DNA was analyzed for the correct insert size using restriction digestion with EcoRI 
(Promega) and agarose gel electrophoresis. 
Plasmids containing the appropriate size insert were prepared for sequencing with 
the BigDye Terminator v3.1 Cycle Sequencing kit (Applied Biosystems).  The reaction 
consisted of 2.0 µl ABI Terminator Ready Reaction mix, 200–500 ng plasmid DNA 
template, 3.2 pmol of M13(forward) or M13(reverse) sequencing primer, and nuclease- 
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Table 1.  PCR primers and conditions for cloning transcription factors xPitx2, 
xPtf1a, Xbh1, and Xbh2. 
The successful primers used for cloning of xPitx2, xPtf1a, Xbh1, and Xbh2.  Included are 
the NCBI Accession Numbers for the sequences used to design the primers, the forward 
and reverse primer sequences, the positions of the primers in the sequences used for 
primer design, melting temperatures of the primers, annealing temperatures used during 
the PCR reaction, and amplicon length as determined by sequencing following cloning 
into pCRII-TOPO.  
18 
 
 
 
  
19 
 
 
 
free water to bring the reaction to 10 µl total volume.  This mixture was heated to 96°C 
for one minute and cycled 25 times at 96°C for 10 seconds, 50°C for 5 seconds, and 60°C 
for 4 minutes.  Once the reaction was complete, 2.5 µl of 125 mM ethylene diamine 
tetraacetic acid (EDTA) disodium salt and 30 µl of absolute ethanol were mixed into the 
reaction, which was incubated at room temperature, spun in a microcentrifuge for 20 
minutes at 4°C, washed with 150 µl 70% ethanol, spun again for 5 minutes at 4°C, and 
dried for 2 minutes in a Savant Speedvac.  The pellet was resuspended in 30 µl Hi-Di 
Formamide (Applied Biosystems) and the resuspension was incubated at 95°C for 5 
minutes before loading into the ABI 3100 Avant automated sequencer (Applied 
Biosystems).  Resulting sequence data were analyzed using Vector NTI Advance 10 
software (Invitrogen) and publicly available BLAST searches against the NCBI 
nucleotide collection (NCBI, http://www.ncbi.nlm.nih.gov/blast/Blast.cgi) to confirm the 
identity of each clone. 
xGlyT2, xVIAAT, and other neurotransmitter phenotype markers were obtained as 
described in Wester et al. (2008).  Clones of xDlx2 and xDlx5 partial coding sequences 
were generously provided by Robert M. Grainger (University of Virginia). 
 
4.3. Antisense RNA probe generation 
Plasmid DNA was obtained using the Quantum Prep Plasmid Midiprep kit 
(BioRad) according to the manufacturer’s protocol with two exceptions.  First, instead of 
growing bacteria in a 50 ml LB liquid media culture until turbid and then pelleting into an 
Oak Ridge tube using a single 10 minute, 5000 RPM spin in a Sorvall RC5B refrigerated 
centrifuge, bacteria were grown in a 150 ml culture and pelleted using a series of 10 
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minute, 7000 RPM spins.  Secondly, instead of performing the final elution with 600 µl 
of sterile, deionized, distilled water, elution was performed with 300 µl of sterile, 
deionized, distilled water in order to maximize the final plasmid concentration.  Probes 
were then linearized by restriction digestion to produce a linear template for in vitro 
transcription using the restriction enzymes shown in Table 2.  After digestion, the linear 
DNA was isolated by successive phenol/chloroform/isoamyl alcohol (25:24:1) extraction, 
chloroform/isoamyl alcohol (24:1) extraction, and ethanol precipitation.  The linear DNA 
was verified to be the appropriate size using agarose gel electrophoresis. 
Linear DNA was transcribed in vitro using standard methods with a 13:7 ratio of 
unlabeled UTP to labeled UTP.  For chromogenic in situ hybridization, digoxigenin-11-
UTP (Roche) was used as the probe label, while for multiplex fluorescent in situ 
hybridization, dinitrophenol-11-UTP (Perkin-Elmer) and fluorescein-12-UTP (Roche) 
were used in addition.  After transcription with either T7 or SP6 RNA polymerase 
(Promega) to produce the antisense RNA strand (Table 2), the template in the reaction 
was destroyed with RQ1 DNase (Promega).  Presence of the RNA transcript was 
confirmed using agarose gel electrophoresis, and the RNA was then purified using the 
RNeasy MinElute Cleanup kit (Qiagen) according to the manufacturer’s protocol and 
confirmed once again using agarose gel electrophoresis.  The RNA was then diluted with 
in situ hybridization buffer and stored at -20°C until used. 
 
4.4. Chromogenic in situ hybridization 
X. laevis embryos obtained from hCG-induced natural matings were fixed in 1X 
MEMFA (3.7% (v/v) formaldehyde, 100 mM 3-morpholinopropane-1-sulfonic acid  
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Table 2.  Linearization and transcription parameters for production of antisense 
RNA probes used for in situ hybridization. 
The restriction enzymes used to linearize plasmids containing cDNA inserts of xDlx2, 
xDlx5, xPitx2, xPtf1a, Xbh1, and Xbh2 for in vitro transcription, and the RNA polymerase 
used during the transcription reaction to produce the antisense RNA fragment. 
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Gene Restriction Enzyme RNA Polymerase 
xDlx2 EcoRI T7 
xDlx5 EcoRI T7 
xPitx2 BamHI T7 
xPtf1a BamHI T7 
Xbh1 EcoRV SP6 
Xbh2 EcoRV SP6 
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(MOPS), 2 mM ethylene glycol tetraacetic acid (EGTA) disodium salt, and 1 mM 
magnesium sulfate in sterile, deionized, distilled water) at room temperature for 90 
minutes and stored in absolute ethanol at -20°C until use.  Sterile, deionized, distilled 
water was prepared for all aqueous solutions by autoclaving (20 minutes at 121°C and 20 
psi) water ultrapurified using a distillation, deionization, UV sterilization, and particulate 
filtration system to 18.2 MΩ-cm resistance (Thermo Fisher Scientific). 
For in situ hybridization, a significantly modified protocol based on Harland 
(1991) was used.  Briefly, embryos were rehydrated, permeabilized with proteinase K, 
treated with acetic anhydride, re-fixed, and prehybridized.  Then, embryos were 
hybridized with antisense RNA probe, washed, RNase treated, and incubated with an 
antibody–alkaline phosphatase conjugate to detect the labeled RNA probe.  Finally, 
unbound antibody was washed out and alkaline phosphatase substrate added to form a 
visible signal. 
In detail, fixed embryos were rehydrated and permeabilized by successive five 
minute washes at room temperature in absolute ethanol, 75% ethanol (aqueous), 50% 
ethanol (aqueous), 25% ethanol in PTw, and finally, four separate washes in PTw.  PTw 
was made up as a solution of 1X phosphate-buffered saline (PBS—2.7 mM potassium 
chloride, 137 mM sodium chloride, 2 mM monobasic potassium phosphate, and 10 mM 
dibasic sodium phosphate in sterile, deionized, distilled water and pH adjusted to 7.5) 
with 0.1% (v/v) Tween-20.  Embryos were then further permeabilized by treatment with 
10 µg/ml proteinase K in sterile, deionized, distilled water for 30 minutes at room 
temperature.  Following permeabilization, embryos were washed three times for five 
minutes each in 0.1 M triethanolamine, treated for five minutes with 0.25% (v/v) acetic 
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anhydride, and treated for five minutes with 0.5% (v/v) acetic anhydride to acetylate 
amine groups, thus reducing background signal.  Embryos were then washed twice in 
PTw, re-fixed in 4% paraformaldehyde in PTw, and washed three times in PTw to 
remove residual paraformaldehyde.  Embryos were introduced to a 20% hybridization 
buffer in PTw mixture to equilibrate and then placed in hybridization buffer and 
incubated for 10 minutes at 60°C.  The hybridization buffer was replaced with fresh 
hybridization buffer and the embryos were incubated at 60°C for at least six hours to 
prehybridize and reduce nonspecific binding upon addition of RNA probe.  Following 
prehybridization, hybridization buffer was replaced with a 1:10 dilution of the stock 
antisense RNA probe in hybridization buffer.  The embryos were then incubated at 60°C 
for approximately 12 hours to allow the probe to hybridize to transcripts. 
Following hybridization, the probe was recovered and washed out of the embryos 
by successive 20 minute washes in 2X SSC (30 mM sodium citrate and 300 mM sodium 
chloride in sterile, deionized, distilled water and pH adjusted to 7.0) at 60°C.  Remaining 
unbound probe was hydrolyzed by a 30 minute treatment with 20 µg/ml RNase A in 2X 
SSC at 37°C.  RNase A was removed by two 10 minute washes in 2X SSC at room 
temperature and two 30 minute washes in 0.2X SSC at 60°C, after which the embryos 
were washed twice for 15 minutes each in maleic acid buffer (MAB—100 mM maleic 
acid and 150 mM sodium chloride in sterile, deionized, distilled water and pH adjusted to 
7.5).  Embryos were then blocked with 2% (w/v) blocking reagent (Roche) in MAB at 
room temperature for one hour.  To detect labeled probe, anti-digoxigenin–alkaline 
phosphatase antibody conjugate (Roche) was diluted 1:2000 in 2% (w/v) blocking 
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reagent in MAB, and 500 µl of the diluted antibody was placed into each vial containing 
embryos.  Antibody detection was carried out at 4°C for approximately 12 hours. 
Unbound antibody was washed out by five successive washes in MAB of at least 
one hour each.  Following these washes, embryos were washed twice for five minutes 
each in alkaline phosphatase buffer (100 mM tris(hydroxymethyl)aminomethane (tris), 50 
mM magnesium chloride, 100 mM sodium chloride, 2 mM tetramisole hydrochloride, 
and 0.1% (v/v) Tween-20 in sterile, deionized, distilled water).  An alkaline phosphatase 
color reaction mixture was prepared by adding 4.5 µl of nitro-blue tetrazolium (NBT) and 
3.5 µl of 5-bromo-4-chloro-3-indolyl phosphate (BCIP) to 1 ml alkaline phosphatase 
buffer.  This mixture (1 ml) was added to each vial containing embryos and incubated at 
room temperature with no agitation until visible color signal developed.  The time until 
the first visible signal ranged from 20 minutes to several hours depending on transcript 
levels and probe strength.  Approximately half of the embryos were fixed once strong 
signal developed but before background increased substantially, rendering them suitable 
for whole mount photography.  The remaining embryos were allowed to continue 
reacting for up to several days regardless of background, rendering them suitable for 
histological analysis.  To stop the color reaction, embryos were placed in 1X MEMFA 
and fixed overnight at 4°C.  Following fixation, embryos were washed for five minutes in 
1X PBS and then stored in fresh 1X PBS at 4°C.  All in situ hybridization experiments 
were conducted with 30 or more embryos, and each individual experiment was replicated 
at least twice.  All embryos were examined under the microscope in detail.  In situ 
hybridization experiments using sense probes were performed as controls to exclude the 
possibility of nonspecific probe binding and verify authentic signal for antisense probes. 
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4.5. Paraffin embedding and sectioning 
Embryos processed with chromogenic in situ hybridization were embedded in 
paraffin and sectioned for histological analysis.  Following fixation and storage in 1X 
PBS, embryos were dehydrated by successive 15 minute washes in 25% ethanol in 1X 
PBS, 50% ethanol in 1X PBS, 75% ethanol in 1X PBS, and absolute ethanol.  Embryos 
were then washed for 15 minutes each in 50% xylenes (mixture of o-, p-, and m- isomers) 
in ethanol and then 100% xylenes.  The embryos were then washed for 15 minutes in 
50% paraffin in xylenes at 62°C, and then washed two times for one to two hours each in 
paraffin at 62°C.  Finally, embryos were placed in fresh paraffin and oriented such that 
the anterior end faced downward in the embedding boats as the paraffin hardened.  
Blocks were allowed to harden for at least 12 hours overnight before proceeding to 
sectioning. 
The blocks were trimmed around the embedded embryo and 10-µm sections were 
taken of the embryos.  Paraffin sections were placed onto Mayer’s albumin adhesive-
treated slides covered with sterile, deionized, distilled water and allowed to dry on a slide 
warmer at 40°C.  Once dried, slides were rinsed in Citrisolv (Fisherbrand) for three to 
five minutes, dried, and cover slipped with Permount (Fisherbrand).  Three drops of 
Permount were applied to the slide surface and a single glass cover-slip was slowly 
lowered onto the slide from one end to the other to minimize bubble formation.  Any 
apparent bubbles over sections were gently pressed to the edge of the slide and excess 
Permount removed.  Cover-slipped slides were allowed to dry at room temperature and 
stored until photographed. 
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4.6. Fluorophore-tyramide synthesis 
Fluorophore-tyramide conjugates for use during the fluorophore deposition of 
fluorescent in situ hybridization were synthesized in a conjugation reaction between 
fluorophore functionalized into a reactive N-hydroxysuccinimide (NHS) ester and 
tyramine hydrochloride.  Fluorophore NHS esters used were Cy3 NHS ester (GE Life 
Sciences), Cy5 NHS ester (GE Life Sciences), and NHS-fluorescein (Pierce 
Biotechnology).  A solution (TEA-DMF) of 1 part anhydrous triethylamine (Sigma) in 
100 parts anhydrous dimethyl formamide (Acros Organics) was prepared by mixing.  
Tyramine hydrochloride (Sigma) was then dissolved to a concentration of 10 mg/ml in 
the TEA-DMF.  Fluorophore NHS ester was brought up to a concentration of 10 mg/ml 
in anhydrous dimethyl formamide.  To conjugate the tyramine to the fluorophore, 33 µl 
of tyramine hydrochloride solution was added to 100 µl of fluorophore-NHS solution, 
inverted to mix well, and incubated at room temperature in the dark for two hours.  
Following this reaction, the fluorophore-tyramide conjugate was diluted in 1.2 ml of 
absolute ethanol, aliquoted, and stored at -20°C (Appendix 1 for detailed protocol). 
 
4.7. Multiplex fluorescent in situ hybridization 
Multiplex fluorescent in situ hybridization was performed identically to the 
chromogenic in situ hybridization protocol except for the modifications described here, 
adopted from Davidson and Keller (1999).  For hybridization, instead of a single probe, 
500 µl of each individual probe were mixed to make the combination probes.  When 
making combinations, the transcript most weakly expressed was paired with a 
digoxigenin-labeled probe, since digoxigenin labeled probes yielded the highest signal-
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to-noise ratio.  Probes were allowed to hybridize at 60°C for between 12 and 16 hours.  
Following RNase treatment and SSC washes, embryos were washed twice in PTw at 
room temperature for 15 minutes each.  Endogenous peroxidases were inactivated with a  
one hour wash in 2% hydrogen peroxide (made by diluting 30% hydrogen peroxide in 
PTw) at room temperature.  Embryos were then washed twice in TBST for 15 minutes 
each at room temperature.  TBST was made up as a solution of 1X tris-buffered saline 
(TBS—12 mM tris and 150 mM sodium chloride, in sterile, deionized, distilled water and 
pH adjusted to 7.5) with 0.1% (v/v) Tween-20.  The embryos were then blocked for 
approximately five minutes with 2% (w/v) blocking reagent in MAB at room 
temperature.  Probes were detected sequentially, starting with the digoxigenin-labeled 
probe.  To detect the probe, anti-digoxigenin–horseradish peroxidase antibody conjugate 
(Roche) was diluted 1:1000 in 2% (w/v) blocking reagent in MAB, and 500 µl of the 
diluted antibody was placed into each vial containing embryos.  Antibody detection was 
carried out at 4°C for approximately 12 hours. 
Unbound antibody was washed out by five successive washes in TBST of at least 
one hour each.  Following these washes, the embryos were washed twice in PTw for 10 
minutes each.  A dilution of fluorophore-tyramide (described above) was made in PTw in 
the dark to prevent photobleaching—these were optimized empirically by qualitatively 
comparing signal-to-noise ratios among depositions with different fluorophore dilutions.  
For Cy3-tyramide, the optimal dilution was 1:25; for Cy5-tyramide, the optimal dilution 
was 1:10; for fluorescein-tyramide, the optimal dilution was 1:200.  For the anti-
digoxigenin–horseradish peroxidase conjugate, Cy3-tyramide was used so that 
fluorescein-tyramide could be used for any anti-fluorescein–horseradish peroxidase 
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conjugate deposition in subsequent steps, to prevent antibody binding of the anti-
fluorescein to any deposited fluorescein-tyramide.  PTw in the vials was replaced with 1 
ml of dilute fluorophore-tyramide and the vials were nutated vertically for 20 minutes to 
allow the fluorophore to penetrate the embryo.  To catalyze the deposition of the 
fluorophore, 3.3 µl of 0.3% hydrogen peroxide (made by diluting 30% hydrogen peroxide 
(aqueous) in PTw) was added to each vial for a final hydrogen peroxide concentration of 
0.001%, and the vials were nutated vertically for 40 minutes.  During this incubation, the 
horseradish peroxidase catalyzed the formation of a covalent bond between the 
fluorophore-tyramide and tyrosine residues of proteins close enough to the antibody 
conjugate for the horseradish peroxidase to act on them (Figure 1).  Following deposition, 
embryos were washed for 15 minutes in TBST. 
To detect a second (or third) probe, embryos were then washed twice in PTw for 
15 minutes each, and antibody–peroxidase conjugates were inactivated by a mechanism-
based inactivation process achieved with a one hour wash in 2% hydrogen peroxide.  
Embryos were then washed twice in TBST for 15 minutes each at room temperature and 
blocked for approximately five minutes with 2% (w/v) blocking reagent in MAB at room 
temperature.  To detect the second (or third) probe, anti-dinitrophenol–horseradish 
peroxidase antibody conjugate (Perkin-Elmer) or anti-fluorescein–horseradish peroxidase 
antibody conjugate (Roche) was diluted 1:1000 in 2% (w/v) blocking reagent in MAB, 
and 500 µl of the diluted antibody was placed into each vial containing embryos.  
Antibody incubation was carried out at 4°C for approximately 12 hours. 
As was done after the first antibody detection, after the second (or third) antibody 
detection, embryos were washed five times in TBST for one hour or more each and 
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Figure 1.  Proposed mechanism for the horseradish peroxidase-catalyzed reaction of 
fluorophore-tyramide with tyrosine residues. 
The theoretical mechanism by which fluorophore-tyramide forms a covalent bond with 
tyrosine residues during the fluorophore deposition step of multiplex fluorescent in situ 
hybridization.  In the presence of a catalytic amount of hydrogen peroxide, horseradish 
peroxidase initiates radical formation on the phenolic oxygens of fluorophore-tyramide 
molecules and tyrosine residues in the cell.  The radicals isomerize and terminate the 
radical chain reaction by forming a covalent bond between the two rings.  The keto-
phenolic rings enolize, forming the final reaction product in which fluorophore-tyramide 
is covalently bound to tyrosine in the cell.  
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washed twice in PTw for 10 minutes each.  A fluorophore dilution in PTw and 
subsequent fluorophore deposition was carried out as described above.  To detect a third 
uniquely-labeled probe and deposit a third fluorophore, the same procedure as used for 
the second detection and deposition was followed.  Once all fluorophore depositions were 
completed, embryos were washed for at least 24 hours in TBST with several solution 
changes to wash out unbound fluorophore.  Cy3 and fluorescein depositions could be 
checked by observation with an epifluorescent stereoscope, though Cy5 could not be 
verified until observed using the confocal microscope with a 633-nm laser excitation.  
Embryos were washed in TBST continuously and observed two to three times daily with 
an epifluorescent stereoscope until no further increase in signal-to-noise ratio was 
observed, after which embryos were fixed in 1X MEMFA and stored in the same manner 
as described for chromogenic in situ hybridization.  All fluorescent in situ hybridization 
experiments were conducted with 30 or more embryos, and each individual experiment 
was replicated at least twice.  All embryos were examined under the microscope in detail. 
 
4.8. Frozen sectioning 
Embryos processed with multiplex fluorescent in situ hybridization were 
cryosectioned for histological analysis, as paraffin embedding diminished the signal-to-
noise ratio in the sections.  Following fixation and storage in 1X PBS, embryos with the 
highest signal-to-noise ratios were selected for sectioning and incubated overnight in 1.6 
M sucrose in sterile, deionized, distilled water at 4°C to cryoprotect the tissue.  Embryos 
were placed in TBS tissue-freezing medium and frozen at -40°C until fully hardened, 
equilibrated to -20°C in the cryostat chamber, and 16-µm sections were taken and placed 
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on gelatin-coated slides.  Slides were allowed to dry fully and were then rinsed for 
approximately five to ten minutes in 1X PBS.  Finally, slides were cover-slipped using 
VectaShield HardSet fluorescent-protecting mounting medium containing 4',6-diamidino-
2-phenylindole (DAPI)  nuclear stain at 1.5 µg/ml (Vector Laboratories).  Two drops of 
medium were applied to the slide surface and a single glass cover-slip was slowly 
lowered onto the slide from one end to the other to minimize bubble formation.  Excess 
medium was absorbed from the edges of the slide, after which the slide was allowed to 
harden and stored at 4°C. 
 
4.9. Imaging 
Images of representative embryos processed by whole mount in situ hybridization 
were taken after fixing and storing in 1X PBS as described above.  In order to fully 
visualize chromogenic signal, whole embryos were cleared by dehydrating in methanol 
(three washes of 10 minutes each) and clearing in a 2:1 mixture of benzyl benzoate and 
benzyl alcohol (BB:BA).  Embryos were viewed in glass dishes in 2:1 BB:BA using an 
Olympus SZH10 research stereoscope, and photographs were taken using an Olympus 
DP71 digital camera. 
Images of representative paraffin-sectioned embryos from chromogenic in situ 
hybridization were viewed on an Olympus BX60 upright compound light microscope, 
and photographs were taken using a Media Cybernetics QCapture digital camera.  All 
images were taken at the highest practical optical magnification available and slides were 
photographed to include a representative series of photographs along the anterior-
posterior axis. 
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Cryosectioned embryos from multiplex fluorescent in situ hybridization were 
initially viewed on an Olympus BX60 upright compound epifluorescent microscope, and 
images for colocalization analysis were taken using a Carl Zeiss LSM510 laser scanning 
confocal and multiphoton microscope paired with a Carl Zeiss 20X apochromatic water 
immersion objective.  The entire anterior-posterior axes of multiple embryos from a 
given multiplex fluorescent in situ hybridization experiment were examined.  
Representative images were taken based upon this examination.  Briefly, this protocol 
was as follows.  The neural tube was centered and magnified to fill the field of view, and 
plane-of-focus adjusted to the center of the Z-axis of the section.  Cy3, Cy5, and 
fluorescein signal or Cy3, DAPI, and fluorescein signal were visualized simultaneously 
using multi-track recording.  Each track was adjusted independently to maximize the 
dynamic range of the image by altering the detector gain such that the maximum signal 
was at the saturation limit, and by altering the amplifier offset such that the background 
was at the detection limit. 
All images were manipulated for minor color, contrast, and brightness adjustment, 
and all figures were compiled and processed in Adobe Photoshop CS3. 
 
4.10. Transcription factor binding site analysis 
Coding sequences for xGAD67, xGAT1, and xVIAAT (GenBank Accession 
Numbers NM_001085801, NM_001095684, and BC057733, respectively) were located 
in the X. tropicalis genome by BLAST search (Joint Genome Institute, http://genome.jgi-
psf.org/Xentr4/Xentr4.home.html).  The 10 kbp upstream and downstream regions of 
each of these genes in the X. tropicalis genome were downloaded and screened for 
35 
 
 
 
transcription factor binding sites using MatInspector (Genomatix Software; Cartharius et 
al., 2005).  Minimum core binding site similarity was restricted to 0.70 and greater, 
overall matrix similarity set to be optimized for function, and vertebrate transcription 
factor binding site weight matrices used for screening.  Binding sites identified for 
Dlx1/2/5 and Ptf1a were recorded, as weight matrices for Pitx2 and BarH are not yet 
available for MatInspector. 
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5. Results 
5.1.  xPitx2, xPtf1a, Xbh1, and Xbh2 clones 
In order to obtain partial clones for X. laevis paired-like homeodomain 
transcription factor 2 (xPitx2), pancreas-specific transcription factor 1a, bar homeobox 
protein 1, and bar homeobox protein 2, RT-PCR was employed using the primers 
described in the previous chapter and Table 1.  For xPitx2, a fragment 748 bp in length 
was amplified that was found to share 99.6% identity with the published X. laevis Pitx2 
mRNA sequence (GenBank Accession Number AF077767).  For xPtf1a, the 624 bp 
fragment produced shared 99.7% identity with the published X. laevis Ptf1a mRNA 
sequence (GenBank Accession Number DQ007931).  The Xbh1 fragment produced was 
1014 bp in length and had a 96.9% nucleotide identity with the published X. laevis Xbh1 
mRNA sequence (GenBank Accession Number NM_001088552).  Finally, for Xbh2, a 
fragment 1002 bp in length was amplified that shared 98.3% identity with the published 
X. laevis Xbh2 mRNA sequence (GenBank Accession Number AF283692) (Appendix 2 
for sequences for all clones). 
 
5.2.  Expression patterns of xDlx2, xDlx5, xPitx2, xPtf1a, Xbh1, and Xbh2 
Whole mount chromogenic in situ hybridization followed by histological analysis 
was used to determine the expression patterns of xDlx2, xDlx5, xPitx2, xPtf1a, Xbh1, and 
Xbh2 throughout development and compare them to those of the GABAergic and 
glycinergic terminal differentiation genes xGAD67, xGlyT1, xGlyT2, and xVIAAT.  xDlx2 
transcripts are first detected early in embryogenesis, and by neurula and early tailbud 
stages, are found in the branchial arches (Fig. 2A).  In agreement with previous reports  
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Figure 2.  Spatial and temporal expression patterns of xDlx2 and xGAD67 in 
developing embryos. 
(A–H) Whole mount in situ hybridization; embryos are viewed laterally, with anterior to 
the left and dorsal to the top.  (A,E) Early tailbud stage embryos.  (B,F) Late tailbud stage 
embryos.  (C,G) Hatching stage embryos.  (D,H) Swimming tadpole stage embryos.  (I– 
T) Transverse 10-µm sections of swimming tadpole stage embryos processed with whole 
mount in situ hybridization, with dorsal to the top.  Schematic diagrams to the left of 
sections indicate the approximate plane of sectioning for each panel.  (A–D,I–N) xDlx2 
expression.  (E–H,O–T) xGAD67 expression.  Abbreviations: br, branchial arch; cg, 
cement gland; di, diencephalon; ey, eye; hb, hindbrain; mb, midbrain; no, notochord; ot, 
otic vesicle; sc, spinal cord; te, telencephalon.  Scale bars represent 1.0 mm. 
  
38 
 
 
 
 
  
39 
 
 
 
(Papalopulu and Kintner, 1993), xDlx2 is expressed in the telencephalon, diencephalon, 
cement gland, otic vesicle, and branchial arches by late tailbud stages (Fig. 2B).  At 
hatching and swimming tadpole stages, xDlx2 mRNA is strongly expressed in the ventral 
telencephalon (Fig. 2C–D,I), medial diencephalon (Fig. 2C–D,J), retina (Fig. 2C–D,K), 
branchial arches (Fig. 2C–D,I–L), otic vesicle (Fig. 2C–D,L), and cement gland (Fig. 
2C–D,I).  The telencephalic and diencephalic expression, as well as the retinal 
expression, appears to occur in the same regions as that of xGAD67 in tailbud, hatching, 
and swimming tadpole stages (Fig. 2F–H,O–Q). 
xDlx5 is expressed first in the presumptive forebrain, otic vesicle, and cement 
gland during neurula and early tailbud stages (Fig. 3A).   As previously reported 
(Papalopulu and Kintner, 1993), by late tailbud stages, xDlx5 mRNA is found in the 
telencephalon, diencephalon, branchial arches, otic vesicle, and cement gland (Fig. 3B).  
This pattern persists and intensifies through swimming tadpole stages, ultimately being 
found in the ventral telencephalon (Fig. 3D,I), medial diencephalon (3D,J), branchial 
arches (Fig. 3D,I–K), otic vesicle (Fig. 3D,L), cement gland (Fig. 3D,I–J), and 
proctodeum (Fig. 3D,N).  As with xDlx2, xDlx5 appears to be expressed in the same 
regions as xGAD67 in the telencephalon and diencephalon (Fig. 3F–H,O–P). 
 xPitx2 mRNA expression is first observed in the cement gland and presumptive 
diencephalon in early neurula stages.  By early tailbud stages, in agreement with previous 
reports (Campione et al., 1999; Essner et al., 2000), xPitx2 is found in the cement gland, 
head mesenchyme, diencephalon, midbrain, retina, spinal cord, and left lateral plate 
mesoderm (Fig. 4B).  This expression pattern continues through hatching stages (Fig. 
4C).  At swimming tadpole stages, xPitx2 expression is no longer observed in the head  
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Figure 3.  Spatial and temporal expression patterns of xDlx5 and xGAD67 in 
developing embryos. 
(A–H) Whole mount in situ hybridization; embryos are viewed laterally, with anterior to 
the left and dorsal to the top.  (A,E) Early tailbud stage embryos.  (B,F) Late tailbud stage 
embryos.  (C,G) Hatching stage embryos.  (D,H) Swimming tadpole stage embryos.  (I– 
T) Transverse 10-µm sections of swimming tadpole stage embryos processed with whole 
mount in situ hybridization, with dorsal to the top.  Schematic diagrams to the left of 
sections indicate the approximate plane of sectioning for each panel.  (A–D,I–N) xPitx2 
expression.  (E–H,O–T) xGAD67 expression.  Abbreviations: cg, cement gland; di, 
diencephalon; ey, eye; hb, hindbrain; hm, head mesenchyme; lp, lateral plate mesoderm; 
mb, midbrain; no, notochord; ot, otic vesicle; pr, proctodeum; sc, spinal cord; te, 
telencephalon.  Scale bars represent 1.0 mm. 
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Figure 4.  Spatial and temporal expression patterns of xPitx2 and xGAD67 in 
developing embryos. 
(A–H) Whole mount in situ hybridization; embryos are viewed laterally, with anterior to 
the left and dorsal to the top.  (A,E) Early tailbud stage embryos.  (B,F) Late tailbud stage 
embryos.  (C,G) Hatching stage embryos.  (D,H) Swimming tadpole stage embryos.  (I– 
T) Transverse 10-µm sections of swimming tadpole stage embryos processed with whole 
mount in situ hybridization, with dorsal to the top.  Schematic diagrams to the left of 
sections indicate the approximate plane of sectioning for each panel.  (A–D,I–N) xDlx5 
expression.  (E–H,O–T) xGAD67 expression.  Abbreviations: br, branchial arch; cg, 
cement gland; di, diencephalon; ey, eye; hb, hindbrain; mb, midbrain; mc, myocardium; 
no, notochord; ot, otic vesicle; sc, spinal cord; te, telencephalon.  Scale bars represent 1.0 
mm. 
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mesenchyme, but is present in the cement gland (Fig. 4D), ventral and medial 
diencephalon (Fig. 4D,J), ventral midbrain (Fig. 4D,K), otic vesicle (Fig. 4D,L), and 
spinal cord (Fig. 4D,M–N).  Additionally, xPitx2 transcripts are present in the outermost 
layers of the retina, possibly corresponding to photoreceptor or pigmented epithelial cells 
(Fig. 4D,J), and unilaterally in the left myocardium and lateral plate mesoderm, but not in 
the right (Fig. 4D,K–L).  The xPitx2 expression observed in the medial diencephalon and 
ventral midbrain occurs in the same regions as xGAD67 expression, and transcripts 
observed in the spinal cord could overlap with xGAD67 or xGlyT2 expression. 
In agreement with Afelik et al. (2006), xPtf1a transcripts are first observed at 
early tailbud stages in the presumptive hindbrain (Fig. 5A).  By late tailbud stages, 
expression extends posteriorly into the anterior spinal cord and appears in the retina (Fig. 
5B).  At hatching stages, xPtf1a transcripts are found in the hindbrain, anterior spinal 
cord, retina, and dorsal and ventral pancreatic buds (Fig. 5C), a pattern that persists 
through swimming tadpole stages (Fig. 5D,I–K).  The neural expression domains appear 
to overlap with xGAD67 expression in similar regions, especially considering the 
established role of xPtf1a in GABAergic retinal development (Dullin et al., 2007) (Fig. 
5E–H,M–O). 
Xbh1 expression, as previously reported (Patterson et al., 2000), is found in the 
presumptive diencephalon in late neurula and tailbud stages (Fig. 6A,B), developing to 
robust expression in the medial diencephalon, dorsal midbrain, and retina by swimming 
tadpole stages (Fig. 6D,N,O).  Weak expression is also detected in the dorsal hindbrain 
by swimming tadpole stages (Fig. 6D,P).  The expression in the diencephalon and 
midbrain may overlap with xGAD67-positive neurons; the retinal expression appears in  
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Figure 5.  Spatial and temporal expression patterns of xPtf1a and xGAD67 in 
developing embryos. 
(A–H) Whole mount in situ hybridization; embryos are viewed laterally, with anterior to 
the left and dorsal to the top.  (A,E) Early tailbud stage embryos.  (B,F) Late tailbud stage 
embryos.  (C,G) Hatching stage embryos.  (D,H) Swimming tadpole stage embryos.  (I– 
P) Transverse 10-µm sections of swimming tadpole stage embryos processed with whole 
mount in situ hybridization, with dorsal to the top.  Schematic diagrams to the left of 
sections indicate the approximate plane of sectioning for each panel.  (A–D,I–L) xPtf1a 
expression.  (E–H,M–P) xGAD67 expression.  Abbreviations: di, diencephalon; dp, 
dorsal pancreatic buds; ey, eye; hb, hindbrain; mb, midbrain; no, notochord; ot, otic 
vesicle; sc, spinal cord; te, telencephalon; vp, ventral pancreatic buds.  Scale bars 
represent 1.0 mm. 
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Figure 6.  Spatial and temporal expression patterns of Xbh1, xGAD67, and xGlyT2 
in developing embryos. 
(A–L) Whole mount in situ hybridization; embryos are viewed laterally, with anterior to 
the left and dorsal to the top.  (A,E,I) Early tailbud stage embryos.  (B,F,J) Late tailbud 
stage embryos.  (C,G,K) Hatching stage embryos.  (D,H,L) Swimming tadpole stage 
embryos.  (M–X) Transverse 10-µm sections of swimming tadpole stage embryos 
processed with whole mount in situ hybridization, with dorsal to the top.  Schematic 
diagrams to the left of sections indicate the approximate plane of sectioning for each 
panel.  (A–D,M–R) Xbh1 expression.  (E–H,S–U) xGAD67 expression.  (I–L,V–X) 
xGlyT2 expression.  Abbreviations: di, diencephalon; ey, eye; hb, hindbrain; mb, 
midbrain; no, notochord; ot, otic vesicle; sc, spinal cord; te, telencephalon.  Scale bars 
represent 1.0 mm. 
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the same areas as xGAD67 and xGlyT1 expression; and the hindbrain expression could 
overlap with that of xGlyT2 (Fig. 6F–H,J–L,T–V).  Xbh2 mRNA is found in similar 
regions and agrees with Patterson et al. (2000) (Fig. 7).  Transcripts are expressed in the 
diencephalon, dorsal midbrain, and dorsal hindbrain by swimming tadpole stages (Fig. 
7D), possibly overlapping with xGAD67 in the diencephalon and midbrain, and xGlyT2 in 
the hindbrain (Fig. 7F–H,J–L,T–V). 
 
5.3. Coexpression of transcription factors with terminal differentiation genes 
To assess the coexpression of transcription factors with terminal differentiation 
genes, whole mount multiplex fluorescent in situ hybridization (FISH) was performed.  
Combinations of various transcription factors and terminal differentiation genes were 
selected based upon possible overlap in expression as indicated by chromogenic in situ 
hybridization.  Experiments and results are summarized in Table 3. 
Whole mount multiplex FISH was used to examine colocalization between the 
xDlx2 and xDlx5 transcripts and the GABAergic marker xGAD67.  In the telencephalon 
and diencephalon, virtually all cells expressing xGAD67 (Cy3, red) also show expression 
of xDlx2 (fluorescein, green); however, the expression pattern of xDlx2 is more extensive 
(Fig. 8A–F).  Additionally, though xGAD67 expression is weak in the retina at hatching 
stages, it appears to colocalize moderately with xDlx2 (Fig. 8G–I).  Likewise, virtually all 
cells in the telencephalon and diencephalon expressing xGAD67 (Cy3, red) also express 
xDlx5 (fluorescein, green) (Fig. 8J–O).  xDlx5 shows a more extensive expression pattern 
than xGAD67 in these regions.  It thus appears that virtually all cells in the forebrain 
expressing xGAD67 also express both xDlx2 and xDlx5.  Whole mount multiplex FISH  
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Figure 7.  Spatial and temporal expression patterns of Xbh2, xGAD67, and xGlyT2 
in developing embryos. 
(A–L) Whole mount in situ hybridization; embryos are viewed laterally, with anterior to 
the left and dorsal to the top.  (A,E,I) Early tailbud stage embryos.  (B,F,J) Late tailbud 
stage embryos.  (C,G,K) Hatching stage embryos.  (D,H,L) Swimming tadpole stage 
embryos.  (M–X) Transverse 10-µm sections of swimming tadpole stage embryos 
processed with whole mount in situ hybridization, with dorsal to the top.  Schematic 
diagrams to the left of sections indicate the approximate plane of sectioning for each 
panel.  (A–D,M–R) Xbh2 expression.  (E–H,S–U) xGAD67 expression.  (I–L,V–X) 
xGlyT2 expression.  Abbreviations: di, diencephalon; ey, eye; hb, hindbrain; mb, 
midbrain; no, notochord; ot, otic vesicle; sc, spinal cord; te, telencephalon.  Scale bars 
represent 1.0 mm. 
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Table 3.  Summary of colocalization analyses performed and results obtained. 
Colocalization between transcription factors and terminal differentiation genes.  Boxes 
indicate results for the central nervous system along the anterior–posterior axis, except 
for grayed boxes, which indicate that the particular combination was not performed.  “No 
coloc.” designates a lack of any colocalization in the particular region, while bolded 
results indicate either colocalization or mutually exclusive expression.  Colocalization is 
shown as a pair of percentages, where the first number is the approximate percentage of 
transcription factor-expressing cells also expressing the terminal differentiation gene, and 
the second number is the approximate percentage of terminal differentiation gene-
expressing cells also expressing the transcription factor.  “Anti” indicates mutually 
exclusive expression between the two transcripts in a single region with no significant 
colocalization.  fb-tel, forebrain–telencephalon; fb-di, forebrain–diencephalon; mb, 
midbrain; hb, hindbrain; sc, spinal cord. 
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  xGAD67 xGAT1 xGlyT1 xGlyT2 xVIAAT 
xDlx2 
fb-tel: 25/100 
      
fb-tel: 25/100 
fb-di: 50/100 fb-di: 50/100 
mb: no coloc. mb: no coloc. 
hb: no coloc. hb: no coloc. 
sc: no coloc. sc: no coloc. 
eye: 10/75 eye: no coloc. 
xDlx5 
fb-tel: 60/100 
      
fb-tel: 60/100 
fb-di: 40/100 fb-di: 40/100 
mb: no coloc. mb: no coloc. 
hb: no coloc. hb: no coloc. 
sc: no coloc. sc: no coloc. 
eye: no coloc. eye: no coloc. 
xPitx2 
fb-tel: no coloc. fb-tel: no coloc. 
  
fb-tel: no coloc. 
  
fb-di: anti fb-di: anti fb-di: no coloc. 
mb: 25/25 mb: 25/25 mb: no coloc. 
hb: no coloc. hb: no coloc. hb: no coloc. 
sc: no coloc. sc: no coloc. sc: no coloc. 
eye: no coloc. eye: no coloc. eye: no coloc. 
xPtf1a 
fb-tel: no coloc. 
  
fb-tel: no coloc. 
    
fb-di: no coloc. fb-di: no coloc. 
mb: no coloc. mb: no coloc. 
hb: no coloc. hb: no coloc. 
sc: no coloc. sc: no coloc. 
eye: 10/75 eye: no coloc. 
Xbh1 
fb-tel: no coloc. 
  
fb-tel: no coloc. fb-tel: no coloc. fb-tel: no coloc. 
fb-di: no coloc. fb-di: no coloc. fb-di: no coloc. fb-di: no coloc. 
mb: anti mb: no coloc. mb: no coloc. mb: anti 
hb: no coloc. hb: no coloc. hb: no coloc. hb: no coloc. 
sc: no coloc. sc: no coloc. sc: no coloc. sc: no coloc. 
eye: no coloc. eye: 30/100 eye: no coloc. eye: no coloc. 
Xbh2       
fb-tel: no coloc. 
  
fb-di: no coloc. 
mb: no coloc. 
hb: no coloc. 
sc: no coloc. 
eye: no coloc. 
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Figure 8.  Colocalization analyses of transcription factors (xDlx2 and xDlx5) and 
xGAD67 in the developing CNS of hatching stage embryos using whole mount 
fluorescent in situ hybridization. 
All images are transverse sections viewed using confocal microscopy, with dorsal to the 
top.  Each group of three images from left to right shows the red channel (Cy3), green 
channel (fluorescein), and a composite image of the red, green, and transmitted light 
channels where yellow represents overlap.  Schematic diagrams to the left of the sections 
indicate the approximate plane of sectioning for a given set of images.  (A–C) xDlx2 and 
xGAD67 in the telencephalon.  (D–F) xDlx2 and xGAD67 in the diencephalon.  (G–I) 
xDlx2 and xGAD67 in the eye.  (J–L) xDlx5 and xGAD67 in the telencephalon.  (M–O) 
xDlx5 and xGAD67 in the diencephalon.  Scale bars represent 100 µm. 
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was also employed to observe colocalization between xPitx2 transcripts and the 
GABAergic markers xGAD67 and xGAT1.  In the midbrain, xPitx2 (Cy3, red) and 
xGAD67 (fluorescein, green) show moderate amounts of colocalization, but also have 
distinct, non-colocalized regions of cells that express one or the other (Fig. 9D–F).  The 
same observation was made when comparing xPitx2 and xGAT1 expression in the 
midbrain.  However, in the diencephalon, xPitx2 (Cy3, red) and xGAD67 (fluorescein, 
green) exhibit expression patterns that occupy the same region, but show virtually no 
cellular coexpression (Fig. 9A–C).  This mutually exclusive pattern was also observed 
when examining xPitx2 and xGAT1 expression in the diencephalon.  In the spinal cord, 
xPitx2 is expressed too dorsally to overlap with either xGAD67 or xGAT1 expression 
(Fig. 9G–I). 
The colocalization between xPtf1a or Xbh1 and the GABAergic marker xGAD67 
was then analyzed.  Whole mount multiplex FISH showed that in the retina, most cells 
expressing xGAD67 (fluorescein, green) also express xPtf1a (Cy3, red), while only a 
small fraction of the cells expressing xPtf1a also express xGAD67 (Fig. 9J–L).  In the 
remainder of the central nervous system, xPtf1a is expressed in regions dorsal to xGAD67 
expression (Fig. 9M–O).  Xbh1 expression (Cy3, red) was found in a pattern mutually 
exclusive to xGAD67 (fluorescein, green) in the midbrain (Fig. 9P–R). 
Possible coexpression of xPtf1a or Xbh1 with the non-neural glycinergic marker 
xGlyT1 was then assessed given the possible overlapping patterns indicated by 
chromogenic in situ hybridization, and both genes’ possible roles in glycinergic amacrine 
cell specification.  No colocalization was found between xPtf1a (Cy3, red) and xGlyT1 
(fluorescein, green)—both are expressed in distinct domains in the central nervous  
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Figure 9.  Colocalization analyses of transcription factors (xPitx2, xPtf1a, and Xbh1) 
and xGAD67 in the developing CNS of hatching stage embryos using whole mount 
fluorescent in situ hybridization. 
All images are transverse sections viewed using confocal microscopy, with dorsal to the 
top.  Each group of three images from left to right shows the red channel (Cy3), green 
channel (fluorescein), and a composite image of the red, green, and transmitted light 
channels where yellow represents overlap.  Schematic diagrams to the left of the sections 
indicate the approximate plane of sectioning for a given set of images.  (A–C) xPitx2 and 
xGAD67 in the diencephalon.  (D–F) xPitx2 and xGAD67 in the midbrain.  (G–I) xPitx2 
and xGAD67 in the anterior spinal cord.  (J–L) xPtf1a and xGAD67 in the eye.  (M–O) 
xPtf1a and xGAD67 in the anterior spinal cord.  (P–R) Xbh1 and xGAD67 in the 
midbrain.  Scale bars represent 100 µm. 
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system and do not overlap in the eye (Fig. 10A–C).  However, all cells in the retina 
expressing Xbh1 (Cy3, red) also show xGlyT1 expression (fluorescein, green) (Fig. 10D–
F).  Because the expression pattern of Xbh1 is more extensive than that of xGlyT1, only a 
moderate fraction of cells expressing xGlyT1 also express Xbh1. 
Next, whole mount multiplex FISH was used to determine possible transcription 
factor colocalization with the neural glycinergic marker xGlyT2.  xPitx2 showed no 
colocalization with xGlyT2 in the spinal cord, as the xPitx2 expression was always more 
dorsal (Fig. 10G–I).  Similarly, neither Xbh1 nor Xbh2 colocalize with xGlyT2 in the 
hindbrain, as the transcription factor expression in both cases was dorsal to that of 
xGlyT2 (data not shown).  In summary, none of the transcription factors analyzed appear 
to colocalize with xGlyT2. 
Finally, the possible coexpression of transcription factors with xVIAAT was 
assessed, since extensive overlap of some transcription factors and xGAD67 was 
observed.  In the telencephalon and diencephalon, the colocalization patterns between 
xDlx2 and xVIAAT appear identical to those for xDlx2 and xGAD67 (Fig. 10J–L).  The 
same observation was made when observing colocalization between xDlx5 and xVIAAT 
(data not shown).  Finally, mutually exclusive expression observed between Xbh1 and 
xVIAAT in the midbrain, identical to that observed between Xbh1 and xGAD67 (Fig. 
10M–O).  Therefore, it appears that xDlx2, xDlx5, and Xbh1 colocalize with the same 
frequencies with xVIAAT as they do with xGAD67 in the telencephalon, diencephalon, 
and mesencephalon. 
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Figure 10.  Colocalization analyses of transcription factors (xPitx2, xPtf1a, and 
Xbh1) and xGlyT1, xGlyT2, and xVIAAT in the developing CNS of hatching stage 
embryos using whole mount fluorescent in situ hybridization. 
All images are transverse sections viewed using confocal microscopy, with dorsal to the 
top.  Each group of three images from left to right shows the red channel (Cy3), green 
channel (fluorescein), and a composite image of the red, green, and transmitted light 
channels where yellow represents overlap.  Schematic diagrams to the left of the sections 
indicate the approximate plane of sectioning for a given set of images.  (A–C) xPtf1a and 
xGlyT1 in the eye.  (D–F) Xbh1 and xGlyT1 in the eye.  (G–I) xPitx2 and xGlyT2 in the 
posterior spinal cord.  (J–L) xDlx2 and xVIAAT in the telencephalon.  (M–O) Xbh1 and 
xVIAAT in the midbrain.  Scale bars represent 100 µm. 
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5.4. Transcription factor binding site analysis 
In order to further examine the role of these transcription factors in inhibitory 
specification using available in silico technologies, transcription factor binding site 
analysis was performed using MatInspector (Genomatix Software; Cartharius et al., 
2005).  Unfortunately, the MatInspector transcription factor weight matrix database is not 
a complete database of all vertebrate transcription factors, and thus only screening for 
Dlx1/2/5 and Ptf1a sites was possible with the software.  Mat Inspector was chosen 
because the other transcription factor binding site analysis programs available for free 
academic use, including rVista 2.0 (NCBI), TFBIND (University of Tokyo), TFSEARCH 
(Computational Biology Research Center), and OFTBS (Tsinghua University), all 
screened for fewer transcription factors 
 For each GABAergic terminal differentiation gene (xGAD67, xGAT1, and 
xVIAAT), 10 kb upstream and downstream regions from the X. tropicalis genome, which 
is over 95% complete and very similar to the X. laevis genome, were screened for binding 
sites.  This analysis showed flanking regions of GABAergic terminal differentiation 
genes contain numerous transcription factor binding sites.  xGAD67 has five upstream 
Ptf1a binding sites, six downstream Ptf1a binding sites, and one downstream Dlx1/2/5 
site.  Similarly, xGAT1 is flanked by three upstream and three downstream Ptf1a binding 
sites, and two downstream Dlx1/2/5 sites.  Finally, xVIAAT has four upstream Ptf1a 
binding sites, one upstream Dlx1/2/5 site, 12 downstream Ptf1a binding sites, and one 
downstream Dlx1/2/5 site.  Perhaps most interestingly, the region between 9 and 10 kb 
downstream of xVIAAT contains many of these sites—a cluster containing seven 
regularly spaced Ptf1a binding sites and a Dlx1/2/5 site is present (Table 4). 
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Table 4.  Transcription factor binding sites in the upstream and downstream 
regions flanking the coding sequences of GABAergic terminal differentiation genes. 
Transcription factor binding sites found by MatInspector.  Position indicates the number 
of base pairs upstream or downstream of the coding sequence where the transcription 
factor binding site is located.  Strand indicates whether the binding site is located on the 
coding strand (+) or template strand (-).  Core identity is the sequence identity of the core 
binding sequence, and matrix identity is the sequence identity of the full binding matrix 
sequence. 
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Term. Diff. Gene Genomic Region Binding Site Position Strand Core identity Matrix identity 
xGAD67 
Upstream 
Ptf1a -3003 (-) 0.857 0.768 
Ptf1a -4555 (-) 0.857 0.763 
Ptf1a -5504 (+) 0.857 0.812 
Ptf1a -5676 (-) 1.000 0.834 
Ptf1a -5753 (+) 1.000 0.798 
Downstream 
Ptf1a 223 (-) 0.857 0.859 
Dlx1/2/5 424 (-) 1.000 1.000 
Ptf1a 855 (-) 0.857 0.767 
Ptf1a 4058 (+) 1.000 0.775 
Ptf1a 5895 (+) 0.809 0.804 
Ptf1a 6513 (-) 1.000 0.771 
Ptf1a 6727 (-) 0.857 0.772 
xGAT1 
Upstream 
Ptf1a -2970 (+) 0.761 0.777 
Ptf1a -7335 (+) 0.809 0.803 
Ptf1a -9663 (+) 0.857 0.760 
Downstream 
Ptf1a 2408 (+) 1.000 0.761 
Ptf1a 3566 (+) 0.809 0.772 
Dlx1/2/5 6045 (-) 1.000 0.910 
Ptf1a 7370 (-) 1.000 0.826 
Dlx1/2/5 9138 (-) 1.000 0.910 
xVIAAT 
Upstream 
Ptf1a -3087 (+) 0.857 0.789 
Ptf1a -3921 (-) 0.857 0.808 
Ptf1a -5368 (-) 0.761 0.833 
Dlx1/2/5 -8486 (+) 1.000 0.910 
Ptf1a -9533 (+) 0.857 0.762 
Downstream 
Ptf1a 73 (-) 0.857 0.808 
Ptf1a 907 (+) 0.857 0.789 
Ptf1a 5126 (+) 0.857 0.774 
Ptf1a 5998 (-) 0.761 0.762 
Ptf1a 6890 (+) 0.761 0.815 
Ptf1a 9174 (+) 0.809 0.778 
Dlx1/2/5 9195 (+) 1.000 0.910 
Ptf1a 9262 (+) 0.857 0.846 
Ptf1a 9351 (+) 0.857 0.846 
Ptf1a 9440 (+) 0.857 0.846 
Ptf1a 9529 (+) 0.857 0.846 
Ptf1a 9618 (+) 0.857 0.846 
Ptf1a 9707 (+) 0.857 0.846 
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6. Discussion 
6.1. Similar colocalization patterns suggest common regulatory mechanisms 
We have observed that colocalization patterns of the GABAergic terminal 
differentiation genes (xGAD67, xGAT1, and xVIAAT) and several transcription factors 
exhibit substantial similarity in certain regions of the developing nervous system.  As 
described in the results, the colocalization observed between xDlx2 and xGAD67 in the 
telencephalon and diencephalon appears to be identical with that observed between xDlx2 
and xVIAAT in the same regions.  A similar phenomenon is observed in the telencephalon 
and diencephalon when examining the colocalization pattern of xDlx5 and xGAD67 and 
comparing it to that of xDlx5 and xVIAAT.   
Likewise, coexpression pattern similarity is observed between xGAD67 and 
xGAT1.  xPitx2 expressing neurons colocalize with both xGAD67 and xGAT1 in the 
midbrain, and are mutually exclusive of both xGAD67 and xGAT1 in the diencephalon.  
This similarity in mutual exclusivity of expression within a region is also observed with 
Xbh1 transcripts, which coregionalize without colocalizing with both xGAD67 and 
xVIAAT in the midbrain.  
The similarity in colocalization patterns between various transcription factors and 
the three primary GABAergic terminal differentiation genes suggests that xGAD67, 
xGAT1, and xVIAAT could be controlled by common regulatory pathways involving these 
transcription factors.  Yu et al. (2003) report that 3.3% of target gene pairs regulated by 
the same transcription factors are coexpressed, a percentage four times greater than 
expected for a random pair of genes.  Indeed, previous reports indicate that in these 
regions of the brain, the expression patterns of xGAD67 and xVIAAT are very similar, not 
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surprising when considering that GAD67 is required for GABA synthesis and VIAAT is 
required for synaptic release of GABA (Wester et al., 2008).  Additionally, xGAT1 has 
been found to colocalize extensively with xGAD67 throughout the central nervous system 
(Daniel Teasley, unpublished).  This indicates that the three primary GABAergic terminal 
differentiation genes, merely by their coexpression with one another, may be regulated by 
a common factor or factors. 
Given that all three exhibit similar coexpression patterns with multiple 
transcription factors, as well as mutual exclusivity with others, it appears even more 
likely that GABAergic terminal differentiation is controlled by a set of transcription 
factors that regulate xGAD67, xGAT1, and xVIAAT.  This is further supported by the 
observation that all three genes share binding sites in the flanking noncoding regions for 
Ptf1a and Dlx1/2/5.  Since the terminal differentiation genes colocalize with these 
transcription factors, it is possible that they are directly regulating transcription of 
GABAergic terminal differentiation during development.  Although transcription factor 
binding site analysis is not available yet for the BarH family of transcription factors, the 
extensive colocalization of Xbh1 and xGlyT1 in the retina indicates that Xbh1 may be 
playing a direct regulatory role in glycinergic amacrine cell specification.  Finally, while 
this study did not identify any transcription factors that colocalize with xGlyT2 
transcripts, it is likely that studies of more transcription factors would identify possible 
candidates as has been done for the GABAergic terminal differentiation genes and the 
glycinergic amacrine cells. 
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6.2. Mutually exclusive expression patterns 
Two of the transcription factors examined—xPitx2 and Xbh1—exhibited a 
phenomenon where the transcription factor was expressed in the same region but in a 
mutually exclusive pattern to GABAergic terminal differentiation genes, resulting in 
virtually no colocalization.  For xPitx2, this occurred in the diencephalon with xGAD67 
and xGAT1, while for Xbh1, it was observed in the midbrain with xGAD67 and xVIAAT 
(Table 3).  Such a pattern is suggestive of two possible regulatory modes by which these 
transcription factors might be acting—either negative or inhibitory regulation, where the 
transcription factor downregulates the expression of GABAergic terminal differentiation 
genes, or signaling pathways, where a transmembrane or secreted ligand causes adjacent 
cells to upregulate the expression of GABAergic terminal differentiation genes. 
Inhibitory mechanisms of regulation have been previously found to be involved in 
neuronal specification with the Tlx3 post-mitotic selector gene.  Tlx3 has been found to 
regulate the glutamatergic neurotransmitter phenotype by inhibiting GABAergic terminal 
differentiation genes (Cheng et al., 2004).  In Tlx3 null mice, GABAergic markers are 
derepressed in prospective glutamatergic neurons.  Furthermore, ectopic expression of 
Tlx3 in the chick spinal cord is able to repress most GABAergic differentiation and 
induce formation of excess glutamatergic populations (Cheng et al., 2004).  Taken 
together, Tlx3 appears to regulate glutamatergic specification by inhibiting GABAergic 
neurotransmitter phenotype specification.  The expression patterns seen for Tlx3 
compared to GABAergic markers are similar to those observed here between xPitx2 or 
Xbh1 and GABAergic markers.  It is possible that these patterns are observed because 
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expression of xPitx2 in the diencephalon and expression of Xbh1 in the midbrain inhibit 
expression of xGAD67, xGAT1, and xVIAAT. 
Juxtacrine mechanisms of regulation, specifically the Notch signaling pathway, 
have also been implicated in neurotransmitter phenotype specification.  It has been shown 
that the Notch pathway plays a critical role in neurotransmitter phenotype specification in 
some systems (Perron and Harris, 2000).  Yun et al. (2002) have found that bHLH and 
homeobox transcription factors can act in concert to regulate Notch signaling activity in 
telencephalon precursors, though the components of the pathway which are being 
regulated have not yet been identified.  In the absence of bHLH transcription factor 
Mash1, Notch signaling was compromised, resulting in an increase of DLX2, Dlx5, and 
GAD67 expressing cells (Yun et al., 2002).  In contrast, Dlx1/2 mutants show increased 
Notch signaling and a resultant decrease in neuronal differentiation, suggesting that 
Mash1 and Dlx1/2 act in a homeostatic manner to upregulate and downregulate Notch 
signaling during development, ultimately controlling neuronal phenotypes (Yun et al., 
2002).  Kabos et al. (2002) have also found that inhibition of Notch signaling increases 
GABAergic progenitors, finding that suppression of HES1, a target transcription factor of 
the Notch intracellular domain, results in increased GABAergic proliferation.  Given the 
mutual exclusivity of expression between xPitx2 and GABAergic terminal differentiation 
genes, as well as Xbh1 and GABAergic terminal differentiation genes, it is possible that 
these transcription factors could be modulating a Notch signaling pathway component, 
resulting in adjacent cells transcribing GABAergic terminal differentiation genes. 
Other signaling pathways could also be responsible for the observed phenomenon 
of mutually exclusive expression.  Gulasci and Lillien (2003) found that sonic hedgehog 
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(Shh) induces GABAergic interneuron production in dorsal telencephalic progenitors, 
while bone morphogenetic protein (BMP) inhibits GABAergic interneurons.  
Furthermore, Shh may be promoting interneuron fate by blocking BMP signaling 
(Gulasci and Lillien, 2003).   Epstein et al. (2000) found that Sim2, a bHLH 
transcriptional regulator, activates Shh.  It is possible that that xPitx2 and Xbh1 act 
similarly to upregulate a signaling molecule like Shh, triggering expression of 
GABAergic terminal differentiation genes in nearby cells. 
 
6.3. Transcription factors may act in combination to regulate specification 
The overlap in transcription factor expression patterns and colocalization patterns 
suggest that inhibitory neurotransmitter phenotype specification occurs via combinatorial 
mechanisms in which multiple transcription factors are necessary for appropriate 
patterning.  First, as noted by Yu et al. (2003), target genes of transcription factors are 
significantly more likely to colocalize when the targets are controlled by multiple 
common transcription factors.  Since significant colocalization is observed between the 
major three GABAergic terminal differentiation genes, it is much more likely that 
multiple transcription factors regulate them than a single transcription factor. 
Just as telling is the overlap between the transcription factors themselves.  xDlx2 
and xDlx5, which have been shown to cross-regulate one another and both of which are 
implicated in inhibitory neurotransmitter phenotype specification (Stühmer et al., 2002), 
show significant overlap in expression patterns in the telencephalon and diencephalon.  
xDlx2 and xDlx5 also show distinct but very similar coexpression patterns with 
GABAergic terminal differentiation genes, suggesting that the two may be acting in 
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concert to regulate GABAergic specification in the forebrain.  Additional evidence is 
observed in the diencephalon, where xPitx2 is expressed mutually exclusive to 
GABAergic terminal differentiation genes.  Thus, in the diencephalon, xDlx2, xDlx5, and 
xPitx2 could all be regulating GABAergic specification together.  In the midbrain, xPitx2 
exhibits moderate colocalization with GABAergic terminal differentiation genes, while 
Xbh1 shows mutually exclusive expression to the same genes.  Regardless of whether 
Xbh1 is acting via an inhibitory or juxtacrine mechanism, it is possible that both xPitx2 
and Xbh1 act in concert to regulate GABAergic specification in the midbrain. 
Finally, the transcription factor binding site data confirm the possibility of 
combinatorial regulation by transcription factors.  Binding sites for multiple transcription 
factors, and significantly, for Dlx1/2/5 and Ptf1a, are found in the flanking regions of 
GABAergic terminal differentiation genes in the X. tropicalis genome.  Given the high 
levels of conservation between the X. laevis and X. tropicalis genomes, these results are 
indicative of binding sites in the X. laevis genome.  While additional evidence in the form 
of in vivo promoter analysis is necessary to confirm the validity of the expression and 
transcription factor binding site data, it seems likely given both sets of data that in at least 
some of the central nervous system, the transcription factors analyzed are acting in a 
combinatorial mechanism to regulate GABAergic specification. 
 
6.4 Future directions 
Several possibilities exist for future studies based upon this research.  Our original 
primary question was to examine if transcription factors mediated the effects of Ca2+ on 
neurotransmitter phenotype identity.  Ca2+ manipulations can be accomplished in X. 
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laevis simply by adjusting the amount of Ca2+ available in the culture medium.  By 
varying Ca2+ concentration, the frequency and amplitude of Ca2+ transients can be 
modulated—if no Ca2+ is available in the extracellular space, Ca2+ spikes and waves will 
not occur.  Performing the analysis conducted in this thesis on embryos cultured in 
varying Ca2+ concentrations and observing perturbations in the transcription factor 
expression patterns and coexpression with terminal differentiation genes will provide 
evidence for or against transcription factor-mediated Ca2+ effects on neurotransmitter 
phenotype.  Another interesting, if more difficult, step would be correlating these data 
directly with Ca2+ activity by electrophysiological or Ca2+-imaging studies on Xenopus 
embryos or single cells.  However, as this study has demonstrated, the coexpression 
patterns of transcription factors, while consistent, implicate several more complex 
transcriptional regulatory mechanisms in neurotransmitter phenotype specification.  
Elucidating how Ca2+ activity regulates a more complex regulatory pathway, such as the 
mediation of signaling pathways or combinatorial transcription factor activity, may be 
difficult. 
The scope of this study could also be expanded to include other transcription 
factors and phenotypes.  For instance, examining xTlx1 and xTlx3 and their roles in 
specifying the glutamatergic terminal differentiation gene xVGlut1 would be a valuable 
step in understanding the relationships between transcription factors and terminal 
differentiation genes (Cheng et al., 2004; Gleason et al., 2003).  This study was unable to 
identify transcription factors that colocalize with the neural glycinergic marker xGlyT2, 
which have yet to be identified in the literature.  An analysis of more transcription factors 
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could identify factors that could be involved in glycinergic specification, a relatively 
unexplored field. 
Finally, and perhaps most interestingly, examining the combinatorial roles of the 
transcription factors in vivo would be a logical next step.  Previous work in this lab has 
identified a 4 kb region upstream of xGAD67 that drives reporter gene expression in a 
tissue-specific pattern nearly identical to the xGAD67 endogenous expression pattern 
using transgenesis in X. laevis (Conor Sipe and David Solomon, unpublished).  Using the 
bioinformatic and expression data gathered here, regions containing binding sites for 
transcription factors that coexpress with terminal differentiation genes could be analyzed 
in vivo for sufficiency in driving reporter gene expression.  Such a study could determine 
more conclusively which transcription factors are involved in specification by including 
regions containing binding sites for specific factors only in the analysis.  Additionally, 
morpholino knockdown and mRNA overexpression experiments in X. laevis could clarify 
any transcription factors’ roles in specifying a given terminal differentiation gene by 
monitoring the terminal differentiation gene expression following knockdown and 
upregulation.  
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Appendix 1: Fluorophore-tyramide synthesis protocol 
 
This protocol details the preparation of the fluorescent-tyramide conjugate solution for 
use in a fluorescent in situ hybridization.  The chemical reaction will only work under 
anhydrous conditions, so reagents should be as fresh as is reasonable.  Dimethyl 
formamide absorbs water once opened, so we use a stock bottle of “extra dry dimethyl 
formamide” from Acros Organics with a rubber septum to prevent moisture entry.  The 
dimethyl formamide must be dispensed by piercing the septum with the needle on a 
syringe, tipping the bottle sideways, and drawing out the needed volume.  Dimethyl 
formamide should be transferred to a microcentrifuge tube and measured for the 
reaction with a pipetteman, as the syringe does not accurately measure volume.  
Dimethyl formamide and triethylamine (the latter in particular) are toxic and 
flammable, and should be handled and dispensed only in the hood.  Fluorophore 
NHS esters (Cy3-NHS, Cy5-NHS, and fluorescein-NHS) are extremely expensive and 
light sensitive, so all work should be performed with the lights out!  Note that the 
quantities are NOT interchangeable for Cy3- or Cy5- verses fluorescein-tyramide 
synthesis, but that for a given fluorophore, the reaction may be scaled to make more or 
less final product. 
 
 
Cy3- or Cy5-tyramide 
 
1. Make DMF-TEA.  Combine the following in a microcentrifuge tube: 
 1 ml  dimethyl formamide (Acros Organics #326871000) 
 10 µl triethylamine (Sigma #T0886) 
 
2. Make tyramide solution.  Combine the following in the vial in which the 
tyramine hydrochloride is shipped: 
 10 mg tyramine hydrochloride (in the vial) (Sigma #T2879-10mg) 
 1 ml DMF-TEA 
 
3. Make a 10 mg/ml stock of Cy3-NHS (or Cy5-NHS) in dimethyl formamide.  
Remember to transfer the dimethyl formamide from the bottle to a 
microcentrifuge tube with a syringe, and measure the amount to add to the Cy3-
NHS (or Cy5-NHS) with a pipetteman!  Combine the following in the vial in 
which the Cy3-NHS (or Cy5-NHS) is shipped: 
1 mg Cy3-NHS (or Cy5-NHS) solid (in the vial) (GE Healthcare #PA13101 for 
Cy3-NHS, #PA15101 for Cy5-NHS) 
 100 µl dimethyl formamide 
 
4. Perform the final reaction in a microcentrifuge tube: 
 100 µl Cy3-NHS in dimethyl formamide 
 33 µl tyramide solution 
 
Mix the tube well by inverting.  Cover the tube with aluminum foil and incubate 
at room temperature for 2 hours. 
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5. Dilute and aliquot.  Add 1.2 ml of 100% ethanol to the reaction and mix well.  
Separate into 200 µl aliquots and store at -20°C protected from light. Dispose of 
the extra tyramide solution into a designated hazardous waste container. 
 
 
Fluorescein-tyramide 
 
1. Make DMF-TEA.  Combine the following in a 15 ml Falcon tube: 
 2 ml  dimethyl formamide (Acros Organics #326871000) 
 20 µl triethylamine (Sigma #T0886) 
 
2. Make tyramide solution.  Combine the following in a 15 ml Falcon tube: 
 20 mg tyramine hydrochloride (weigh carefully on the balance) (Sigma #T2879) 
 2 ml DMF-TEA 
 
3. Make a 10 mg/ml stock of fluor-NHS in dimethyl formamide.  Combine the 
following in a 15 ml Falcon tube: 
40 mg fluor-NHS solid (weigh carefully on the balance) (Pierce Biotechnology 
#46100) 
 4 ml dimethyl formamide 
 
4. Perform the final reaction in a 15 ml Falcon tube: 
 4 ml fluor-NHS in dimethyl formamide 
 1.37 ml tyramide solution 
 
Mix the tube well by inverting.  Cover the tube with aluminum foil and incubate 
at room temperature for 2 hours. 
 
5. Dilute and aliquot.  Add 4 ml of 100% ethanol to the reaction and mix well.  
Separate into 1 ml aliquots and store at -20°C protected from light.  Dispose of 
the extra tyramide solution into a designated hazardous waste container. 
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Appendix 2: Transcription factor clone sequences 
xPitx2 full sequence:
 
 
xPtf1a full sequence:
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Xbh1 sequence from M13(forward) sequencing primer (5' end of Xbh1)*:
 
 
 
 
Xbh1 sequence from M13(reverse) sequencing primer (3' end of Xbh1)*:
 
 
 
 
*Due to a clone length of over 1000 bp, full sequences were unable to be obtained 
without sequencing using internal primers.  As such, the sequences obtained from 
sequencing primers in the vector are reported here.  
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Xbh2 sequence from M13(forward) sequencing primer (5' end of Xbh2)*: 
 
 
 
 
Xbh2 sequence from M13(reverse) sequencing primer (3' end of Xbh2)*: 
 
 
 
 
*Due to a clone length of over 1000 bp, full sequences were unable to be obtained 
without sequencing using internal primers.  As such, the sequences obtained from 
sequencing primers in the vector are reported here. 
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